objectives To determine the average time in months between the beginning of symptoms and the diagnostic confirmation of leprosy by the health system and to investigate factors associated with diagnostic delay.
Introduction
Leprosy is a mycobacterial disease caused by Mycobacterium leprae, a bacterium that principally affects the skin, soft tissues, the peripheral nervous system and the eyes. Leprosy is characterised by a very long incubation period and a rather insidious course of disease [1] . However, as disease progresses, it may lead to severe complications such as nerve damage with resulting hypoesthesia, anaesthesia or paresis of the respective body part, disfigurement and to particularly grave or visible forms of disability, often referred to as Disability Grade 2 (DG2) [2] . The disfiguring and disabling aspect of the disease is one of the main causes of the leprosy-specific stigma, which aggravates the suffering of people affected as they often become subject to marginalisation and discrimination [3] . Although continuous elimination efforts over the past decades have led to a significant decrease in the burden of leprosy and thus to a deprioritisation of its control, the disease remains one of the leading causes of preventable disability worldwide [4] .
Timely diagnosis and treatment of leprosy is not only key for interrupting its transmission, but also key for preventing physical and social complications and thus reducing the burden of the disease. As prolongation of diagnostic delay is increasing the likelihood of nerve damage with subsequent disability, DG2 is used often used as a proxy indicator for delayed diagnosis [5] . Thus, the stagnation of DG2 rates among new cases observed lately on global scale could be indicative of significant diagnostic delay worldwide [6] . Indeed, various studies from different countries have found substantial delay in diagnosis of leprosy. Depending on the context, a number of factors reaching from sociodemographic characteristics and health-seeking behaviour to health system performance have been found to be accountable [7, 8] .
Colombia, as other low-endemic countries, exhibits a highly clustered occurrence pattern of leprosy at sub-national level, with the north-eastern part of the country bearing the main burden of disease [9] . In the period 2010-2015, the Ministry of Health (MoH) launched and implemented a strategic plan aiming at alleviating drastically the burden of disease particularly in observed leprosy clusters and sustaining leprosy control activities nationwide. However, these systematic efforts had little effect on key leprosy indicators like DG2 that remained strikingly high in the past 10 years, ranging from 9% to 17% among new cases detected. [6] . These figures could be suggestive of a systematic delay in diagnosis and treatment of leprosy in the country. Despite this fact, little is known about the true magnitude of the delay in diagnosis and treatment of leprosy and its underlying factors in the Colombian context. In a prior study, the mean time elapsed from symptom onset to diagnosis was found to be 2.9 years [10] . However, as the study used data from a single tertiary care level hospital in Bogota, these findings are not generalisable.
In this light, we explored the delay of diagnosis of leprosy and its underlying factors by interviewing people affected by leprosy and reviewing data from health facilities in five endemic departments of the north-eastern part of the country.
Material and methods

Study design
Patients older than 15 years diagnosed with leprosy between 2011 and 2015 in the departments of Atl antico, Bol ıvar, Norte de Santander, Magdalena and Santander were eligible for this study. Names and addresses of the patients were obtained from the health secretariats and the hospitals of the five departments. Members of the Associations of People Affected by Leprosy also helped to trace the eligible patients. Potential study participants were invited by telephone to a group meeting, in which the purpose of the investigation was explained. Those not able to attend the meeting, but expressing interest in participating, were visited later at home by members of the study team. After giving informed consent, participants were interviewed individually under conditions of strict confidentiality. For the face-to-face interview, we used a self-constructed survey format questionnaire (Annex 1). The interviews were conducted between July and October 2016. In addition to the patient's personal data (name, identification, address and telephone number), the questionnaire included 14 questions, with multiple choice and/or open end responses. Participants answered the survey questions verbally, and their answers were written down by research assistants. Clinical charts of study participants from health centres or hospitals where they were treated for leprosy were reviewed and relevant data were collected according to a defined formula (Annex 2).
Study population
Two hundred and fifty patients (49.4%) of a total of 508 notified cases with leprosy between 2011 and 2015 in the aforementioned departments, provided informed consent to participate in the study. They resided in 20 endemic municipalities of the departments of Atl antico (six municipalities), Bol ıvar (two municipalities), Norte de Santander (four municipalities), Magdalena (three municipalities) and Santander (five municipalities). One participant had to be excluded due to implausible values. The final analytical sample comprised 249 patients with leprosy.
National Leprosy Care Guide
According to the Leprosy Care Guide of the MoH of Colombia, diagnosis of the disease is based on the clinical evaluation, focusing on the examination of dermatological, ophthalmological, otorhinolaryngological, osteoarticular and neural lesions. Skin lesions should be examined in a systematic manner, comparing them with the unaffected skin, performing an exploration of the thermal, pain and tactile sensitivity, as well as the palpation of the nerve trunks. Skin smear microscopy is recommended in suspected and/or all clinically confirmed cases, to have an additional classification criterion [i.e. multibacillary (MB), if the result of the test is positive (bacillary index > 0) irrespective of the number of skin lesions or paucibacillary (PB), if the result is negative (bacillary index = 0)]. In addition, the guide indicates that a negative skin slit smear does not rule out the diagnosis of leprosy and that in case of inconclusive clinical findings, a skin biopsy from a suspected skin lesion should be performed.
Ethical considerations
This study was approved by the Ethics Committee of the Universidad Metropolitana of Barranquilla (ethical clearance registration number: 070, 12.06.16). According to the national law, informed consent of minors participating in the study was given by their parents.
Statistical analysis
The outcome variable was the time elapsed from presentation of first symptom to diagnosis and is referred to as diagnostic delay in this study. It was calculated in months based on the data obtained from the clinical records (i.e. date of diagnosis minus date when first signs and symptoms have been noticed by the patient). Data on the covariates of the study obtained from the surveys and the review of clinical records were categorised in four categories:
• Sociodemographic data including information on sex, department of residence (Atl antico, Bol ıvar, Norte de Santander, Magdalena and Santander), place of residence (rural/urban), level of education, age group, health insurance scheme (fully subsidised/contributory);
• Data on potential patient 0 s related delay factors: seeking care immediately after notice of the first symptom (yes/no and if no why), suspicion of symptoms being due to leprosy (yes/no);
• Data related to clinical characteristics: type of leprosy (multibacillary/paucibacillary), DG at diagnosis (0 = no disability at all, 1 = non-visible disability/sensory loss, 2 = visible disability); and
• Data related to the health system performance: number of consultations needed until final diagnosis has been reached, misdiagnosis and mistreatment (yes/no), examination confirming the diagnosis, health professional making the final diagnosis (nurse/medical doctor/dermatologist/other health staff), incidental diagnosis in asymptomatic patient (yes/no).
We calculated the distribution in percentages for categorical variables and the median, median interquartile range and mean with standard deviation (SD) for the numerical variables. To determine the association among the factors related to the delay in the diagnosis of leprosy, we performed a univariable linear regression analysis between the outcome variable (delay in months) and the variables, with exception of DG which as mentioned above is an established proxy of diagnostic delay. In a second step, we performed a multivariable linear regression analysis including in the model all those variables which exhibited a significant association with the outcome variable in the univariable regression. The level of significance was 0.05. All analyses were performed using STATAIC 12.
Results
The median diagnostic delay was 19 months with an interquartile range of 9-40 months. The mean diagnostic delay was 33.5 (SD: 42) months. The majority of participants were males in urban settings. Almost four of five had some form of formal education, only one of three had a contributory insurance scheme. About 63% of patients had a multibacillary leprosy manifestation and almost 15% had signs of DG2 at the time of diagnosis (Table 1) .
Only 31.3% of patients sought professional help directly after noticing the first symptom, while solely 10% suspected leprosy to be its cause. Only 17.7% of the study participants had their disease diagnosed at the first consultation; the vast majority experienced misdiagnosis and mistreatment. In half of the cases, the diagnosis was confirmed by a dermatologist ( Table 2) .
In univariable analysis, diagnostic delay was independent of most of the sociodemographic factors with exception of the department patients resided in. In addition, two variables indicative of the health system performance, that is the number of consultations needed to confirm diagnosis and the group of health professionals diagnosing the disease, were significantly associated with the diagnostic delay in leprosy. Seeking care immediately after noticing the first symptom was associated with significantly shorter diagnostic delay. In the subsequent multivariable linear regression analysis, the statistical significance of these associations could be confirmed only for two of the aforementioned factors, namely seeking care immediately after noticing the first symptoms and number of consultations needed to confirm diagnosis (Table 3) . A total of 171 participants reporting not seeking care immediately after noticing first symptoms were asked for the reasons for not doing so. While in some cases, delay in health seeking was due to fear of being diagnosed with a severe illness and lack of money, the overwhelming majority indicated that they did not consider the symptoms important enough to seek care (Table 4) .
Discussion
This study, comprising data of patients from 20 endemic municipalities in northern Colombia, shows that there is a substantial diagnostic delay in the diagnosis of the leprosy. Not seeking care immediately after notice of the first symptoms and five or more consultations needed for establishing diagnosis were independently associated with a longer diagnostic delay.
The mean for delay in the diagnosis of leprosy found in this study was 33.5 months. This finding is substantially higher than the mean delay found in studies in other countries [11, 12] and similar to the mean diagnostic delay recorded in a previous Colombian study conducted in a tertiary Dermatological Centre in Bogot a [10] . In line with the aforementioned study and the literature, we also found a relation between diagnostic delay and DG2. Indeed, the mean diagnostic delay in DG2 was significantly higher than in patients with DG1 or no disability at all at diagnosis (data not shown). About 14.9% of our study population exhibited DG2, a figure which is in accordance with the annual DG2 rates among new leprosy cases notified at the national level [6] . Although DG2 rates and average diagnostic delay found in our study seem to match the national average, as patients included in this study reside in areas known to be endemic, our results indicate that leprosy remains a severely neglected disease in the north-eastern Colombia.
A total of 224 (89.2%) of the patients surveyed lived in urban areas, where it is easier to access medical consultation than those living in rural areas. Interestingly, rural residence was not significantly associated with diagnostic delay of leprosy. Delay in diagnosis of leprosy was independent from a number of sociodemographic factors such as sex, age, level of education and type of health insurance scheme. When stratifying by geographical department of residence, there was some geographical heterogeneity in terms of the length of diagnostic delay observed, which however could not be confirmed in the multivariable regression analysis.
Remarkably, 70% of the patients stated that their condition was initially misdiagnosed and mistreated. The most common misdiagnosis reported was fungal skin disease and skin allergy (data not shown). However, we failed to detect a significantly longer diagnostic delay in patients that were initially misclassified. In contrast to that, two further variables reflecting health system performance, namely, the number of consultations needed to establish diagnosis and the category of health professional diagnosing the disease were significantly associated with diagnostic delay in the univariable regression analysis. Nevertheless, statistical significance in the multivariable model could be confirmed only in the case of the number of consultations. In particular, we found that patients needing five or more consultations exhibited on average a diagnostic delay that was 24.4 months longer that the patients diagnosed in the initial consultation. With respect to the patient's related delay factors, not seeking heath care immediately after notice of the first symptom was strongly associated with diagnostic delay even after multivariable regression. In the overwhelming majority of the cases, not seeking care immediately after notice of the first symptom was not the result of impaired geographical, cultural or financial access to health care but rather due to trivialisation of the initial symptoms of leprosy by the patients themselves. This result, read in conjunction with the fact that only 1 of 10 patients suspected leprosy before diagnosis by a health professional, can be interpreted as a sign of a significant lack of disease awareness in the general population. Our findings are in accordance with a number of previous studies suggesting that lack of disease awareness among the patients is one of the key factors contributing to delayed diagnosis of leprosy worldwide [13, 14] .
To our knowledge, this is the first study exploring the dimension of diagnostic delay in leprosy and its underlying factors in north-eastern Colombia. Although inclusion of detailed information on sociodemographic characteristics and both patient and health system-dependent delay factors certainly contributes to the robustness of our results, our study exhibits some limitations. Due to the relatively small sample size and the relative underrepresentation of some sub-groups, such as female and rural residents, our study might have failed to detect all potential associations between diagnostic delay and the included variables. Also, as our study was not able to include all notified cases in the time period between 2011 and 2015, the possibility of some degree of selection bias cannot be ruled out. Indeed, compared to the total of 508 cases reported throughout the period of 2011-2015, our study population exhibits a slightly higher DG2 and MB proportion, suggesting that patients with more severe manifestations were more likely to participate in the study. Also, social acceptability bias may have led participants to denial of answers which, in their perception, could have made them culpable for the diagnostic delay. Finally, a further limitation of our study is that answers of the participants could be subject to recall bias, as patients are interviewed in some cases even 6 years after diagnosis of disease.
In conclusion, our study suggests that diagnostic delay is substantial in the endemic north-eastern Region of Colombia. Underlying factors are both patient-and systemdependent. Diagnostic delay is substantial in the endemic north-eastern Region of Colombia. Lack of disease awareness among the general population and many consultations -suggestive of ill-trained health staff in suspecting and managing a leprosy case -were associated with longer diagnostic delay, contributing thus to the ongoing transmission and disability-related disease burden. Interventions creating awareness of early signs of leprosy among the general population might drastically shorten the diagnostic delay. Implementation of a patient-centred step-wise referral system based on a clinical algorithm might reduce the number of consultations needed to confirm a leprosy diagnosis, thus shortening diagnostic delay.
